Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
12/2003
12/31/2003WO2004000807A1 Cannabinoid receptor agonists
12/31/2003WO2004000797A1 Alpha-sulfonylamino-acetonitriles
12/31/2003WO2004000789A1 Amide linker peroxisome proliferator activated receptor modulators
12/31/2003WO2004000783A1 Aminoalkylphenols, methods of using and making the same
12/31/2003WO2004000779A1 Process for producing phenyloxocarboxylic ester derivative
12/31/2003WO2004000762A2 Propionic acid derivatives and their use as hppars activators
12/31/2003WO2004000315A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
12/31/2003WO2004000295A1 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/31/2003WO2003088959A3 Treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s)
12/31/2003WO2003066558A3 Production of alkenones
12/31/2003WO2003065991A3 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
12/31/2003WO2003063576A3 Arylsulfonamidobenzylic compounds
12/31/2003WO2002048110A3 Composition for regulating animal growth, method of manufacture and use thereof
12/31/2003CN1464871A Compound for organic el element and organic el element
12/31/2003CN1132817C Process for preparation of heteroarylcarboxamides
12/31/2003CN1132816C 2－吡啶基甲胺衍生物及其应用和杀虫剂组合物 2-pyridyl methyl amine derivatives and their application and insecticidal composition
12/31/2003CN1132815C 杂芳香族醛类的制造方法 The method of manufacturing the heteroaromatic aldehyde
12/31/2003CN1132516C Amino-acetonitrile derivative, pesticides containing same for farm and gardening and use thereof
12/31/2003CA2490687A1 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/31/2003CA2490646A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors
12/31/2003CA2489359A1 Propionic acid derivatives and their use as hppars activators
12/31/2003CA2488972A1 Amide linker peroxisome proliferator activated receptor modulators
12/31/2003CA2487909A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
12/31/2003CA2487346A1 Cannabinoid receptor agonists
12/30/2003US6670645 Bright, efficient, stable; increased volatility for lower temperature vacuum deposition preventing decomposition
12/30/2003US6670480 Process for preparing substituted pyridines
12/30/2003US6670478 Process for preparing torsemide intermediate
12/30/2003US6670473 Inhibitors of nitric oxide synthase (nos)
12/30/2003US6670400 Secretion inhibitors for gastric acid, antiemetics; N(4-(2-(2-methoxyphenoxy)ethyl)aminobutyl)benzamide;
12/30/2003US6670382 Hydroxyformamidine derivatives and medicines containing the same
12/30/2003US6670381 Benzamide derivatives as thrombin inhibitors
12/30/2003US6670380 Pyridone inhibitors of fatty acid binding protein and method
12/30/2003US6670376 Aryl aniline β2 adrenergic receptor agonists
12/30/2003US6670370 Cough suppression; reacting dextromethorphan with tannic acid
12/30/2003US6670358 Substituted thioacetamides
12/29/2003CA2433983A1 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
12/25/2003WO2003106572A1 Printing process using specified azo compounds
12/25/2003US20030236435 Synthesis of 2-alkylcysteine via substituted thiazoline ester
12/25/2003US20030236434 Condensing cysteine with cabocyclic nitriles to form 2-arylthiazoline-4-carboxylic acid, then amidation, alkylation, hydrolyzing and optionally purifying to form 2-methylcysteine
12/25/2003US20030236426 Synthesis of benzimidate from benzoic acid
12/25/2003US20030236415 Etherifying mucochloric or mucobromic acid with an alcohol, alkylation, hydrogenation, dehydrochlorination or dehydrobromination, decyclization by reductive amination and carboxylation; 3-Aminomethyl-5-methyl-hexanoic acid
12/25/2003US20030236413 Catalysis in presence of a metallic element, an imine ligand and nitrogen compound as chelating compound, forming a chemical intermediates in the agrochemical and pharmaceutical fields
12/25/2003US20030236404 Synthesis of 2-alkylcysteine via phase transfer catalysis
12/25/2003US20030236287 Central nervous system disorders; analgesics; antiinflammatory agents; cognition activators; anticancer agents; antidiabetic agents
12/25/2003US20030236286 Central nervous system disorders; cardiovascular disorders; antiischemic agents; psychological disorders
12/25/2003US20030236280 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
12/25/2003US20030236274 Naphthalene derivatives, their production and use
12/25/2003US20030236261 Potassium channel inhibitors
12/25/2003US20030236259 Novel aryl- and heteroarylpiperazines
12/25/2003US20030236257 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the cogulation cascade
12/25/2003US20030236248 Kappa agonist compounds and pharmaceutical formulations thereof
12/25/2003US20030236231 Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
12/25/2003US20030236220 Mucin synthesis inhibitors
12/25/2003US20030236213 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/25/2003US20030236212 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/25/2003US20030235843 For use as radiopharmaceuticals; solid phase synthesis; G-protein-coupled receptors
12/25/2003US20030235612 Compounds and compositions for delivering active agents
12/24/2003WO2003106610A1 Use of transition metal complexes with nitrogen-containing polydentate ligands as a bleaching catalyst and bleaching agent composition
12/24/2003WO2003106420A1 2,5-disubstituted 3-mercaptopentanoic acid
12/24/2003WO2003106419A1 Room-temperature molten salt, process for producing the same and applications thereof
12/24/2003WO2003106405A1 Aspartyl protease inhibitors
12/24/2003WO2003106402A1 2-naphtamide derivatives
12/24/2003WO2003106381A2 Human adam-10 inhibitors
12/24/2003WO2003086396A9 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
12/24/2003WO2003084916A3 Compounds that modulate ppar activity and methods for their preparation
12/24/2003WO2003072548A8 Pyridyl sulfone derivatives as 5-ht receptor antagonists
12/24/2003WO2003064685A3 Genetic polymorphisms in the preprotachykinin gene
12/24/2003WO2003039454A3 Beta-secretase inhibitors and methods of use
12/24/2003WO2003019697A3 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
12/24/2003CN1463263A Method to inhibit ethylene responses in plants
12/24/2003CN1131670C Antifungal active compound compsns.
12/24/2003CA2493874A1 Use of transition metal complexes with nitrogen-containing polydentate ligands as a bleaching catalyst and bleaching agent composition
12/24/2003CA2489286A1 2-naphtamide derivatives
12/24/2003CA2489095A1 Aspartyl protease inhibitors
12/24/2003CA2488606A1 2,5-disubstituted 3-mercaptopentanoic acid
12/24/2003CA2485346A1 Human adam-10 inhibitors
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667402 Reacting a vinyl pyridine with hydrogen sulfide in presence of a tertiary amine
12/23/2003US6667398 Reacting a benzamidine compound with a amide substituted pyrazole compound
12/23/2003US6667342 Benzenesulfonamide-derivatives and their use as medicaments
12/23/2003US6667327 Pyridine amido derivatives
12/23/2003US6667315 Pyridoxine phosphonate analogues such as, for example, ((2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)alkylphosphonates, and (2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)azaalkylphosphonates)
12/23/2003CA2233178C (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/18/2003WO2003104333A1 Yellow anionic disazo dyes
12/18/2003WO2003104195A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003WO2003104184A1 Methods for synthesis of acyloxyalkyl derivatives of gaba analogs
12/18/2003WO2003104181A2 Compounds that abrogate dna-damage-induced cell cycle g2 checkpoint and/or augment the anti-cancer activity of dna-damaging treatments
12/18/2003WO2003103668A1 Pyridin-2-one and quinolin-2-one derivatives, preparation thereof and use thereof as antibacterials
12/18/2003WO2003103667A1 Inhibitors against complex ii of electron transport system
12/18/2003WO2003103656A1 O-substituted hydroxyaryl derivatives
12/18/2003WO2003103599A2 Caspase-1 inhibitors and methods for their use
12/18/2003WO2003103567A2 Nitrosodiphenylamine derivatives, compositions comprising them, and the use thereof as antioxidants and spontaneous nitric oxide donors
12/18/2003WO2003074467A3 Urea derivatives as hiv aspartyl protease inhibitors
12/18/2003WO2002064567A8 Substituted carboxamides as inhibitors of factor xa
12/18/2003WO2002057492A9 Methods and compositions for detecting polynucleotide duplex damage
12/18/2003WO2001078648A3 6-methylnicotinamide derivatives as antiviral agents
12/18/2003US20030232995 Extruding through an orifice, cooling to form granule; chemical intermediates to form 4-dimethylaminopyridine catalyst, use for catalyzing acylation reactions in the pharmaceutical and agricultural industries
12/18/2003US20030232989 Process for the preparation of specific aromatic aldehydes
12/18/2003US20030232985 For therapy of Alzheimer's disease and Down's Syndrome
12/18/2003US20030232864 Novel Compounds and compositions as protease inhibitors
1 ... 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 ... 633